Ropivacaine: A Novel AKT1 Inhibitor Affecting Breast Cancer Stemness
The following is a summary of “Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer,” published in the March 2024 issue of Oncology by Ding et al. Ropivacaine, a widely used local anesthetic, has demonstrated anti-tumor properties...